Biotech CARsgen’s Claudin18.2 CAR-T Therapy Satri-cel Granted Breakthrough Therapy Designation by the NMPA March 3, 2025
Biotech POSITIVE RESULTS FROM TEZSPIRE® (TEZEPELUMAB-EKKO) PHASE 3 WAYPOINT TRIAL HIGHLIGHT RAPID, SUSTAINED EFFECT IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS March 2, 2025
Biotech New independent studies show that ColdZyme addresses the root cause of respiratory infections, reducing sick days and symptoms March 1, 2025
Biotech FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review February 26, 2025
Biotech NMPA Accepts NDA and Grants Priority Review Designation to Innovent’s Ipilimumab Injection, China’s First Domestic CTLA-4 Inhibitor, in Combination with Sintilimab as Neoadjuvant Treatment for Colon Cancer February 24, 2025
Biotech Esphera SynBio’s Exosome Tech Featured on Advancements with Ted Danson on the Bloomberg cable and satellite network February 23, 2025
Biotech FDA Approves First Treatment for Cerebrotendinous Xanthomatosis, a Rare Lipid Storage Disease February 22, 2025